FAKTOR-OPTIONSSCHEIN - SMITH & NEPHEW | Market Closed - Börse Stuttgart 08:17:01 24/05/2024 pm IST | ||
| 10.17 EUR | +2.21% |
|
| Current month | -0.20% | ||
| 1 month | +1.29% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
SMITH & NEPHEW PLC
Latest news about SMITH & NEPHEW PLC
| Date | Price | Change |
|---|---|---|
| 24/24/24 | 10.17 | +2.21% |
| 23/24/23 | 9.95 | +15.43% |
| 22/24/22 | 8.62 | -2.27% |
| 21/24/21 | 8.82 | +10.53% |
| 20/24/20 | 7.98 | -3.74% |
Delayed Quote Börse Stuttgart
Last update May 24, 2024 at 08:17 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | SMITH & NEPHEW PLC |
| Issuer | Morgan Stanley |
| WKN | MG2XMB |
| ISIN | DE000MG2XMB8 |
| Date issued | 24/04/2024 |
| Strike | 1,179 p |
| Maturity | Unlimited |
| Parity | 0.23 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.39 € |
|---|---|
| Lowest since issue | 7.94 € |
| Spread | 0.06 € |
| Spread % | 0.58% |
Company Profile
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Sector
-
Consensus: Smith & Nephew Plc
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
12.48
USD
Average target price
16.34
USD
Spread / Average Target
+30.93%
- Stock Market
- Certificates
- Certificat
